BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 10, 2016
View Archived Issues
Pfenex announces positive phase Ia results for Px-563L anthrax vaccine
Read More
Charles River enters strategic partnership with Milner Therapeutics Institute and Consortium
Read More
Pfizer patents modulators of RORgamma t
Read More
Pfenex to regain full rights to the biosimilar candidate PF-582
Read More
Confluence Life Sciences discloses ITK kinase inhibitors
Read More
Actelion Pharmaceuticals develops CXCR3 receptor antagonists
Read More
Helsinn Group and MEI Pharma enter strategic agreement to develop pracinostat
Read More
Kissei and JCR initiate phase III clinical trial of the biosimilar agent JR-131
Read More
Vonvendi launched in the U.S. as the first and only recombinant von Willebrand factor treatment
Read More
Tafamidis demonstrates long-term benefits in transthyretin hereditary amyloid polyneuropathy
Read More
Ablynx reports topline phase IIb results for vobarilizumab in patients with rheumatoid arthritis
Read More
NIH awards a new contract to the IAVI to advance AIDS vaccine development
Read More
Mitsubishi Tanabe Pharma reports highlights of first quarter of fiscal 2016
Read More
Adverum and Editas collaborate on genome-editing medicines
Read More
Pluristem Therapeutics' critical limb ischemia program awarded USD 8 million
Read More
BMI1 shows promise as a target in lung cancer patients with loss of C/EBPalpha expression
Read More
Summit Therapeutics shows positive phase I results for new ezutromid formulation
Read More
Aldeyra Therapeutics reports positive results for NS-2 trial
Read More
Teijin and Versartis enter strategic alliance for development and commercialization of somavaratan
Read More
Celsion signs long-term agreement with Zhejiang Hisun Pharmaceutical for EGEN-001
Read More
Fevipiprant shows favorable efficacy and safety in persistent eosinophilic asthma
Read More
Biogen set to launch new standalone company named Bioverativ next year
Read More
Medical Research Council awards funding for development of new tests for bacterial infections
Read More
GRP45 shows promise as a therapeutic target for obesity
Read More
